Back to search
Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP) trials you may qualify forThis is a 3-part Phase 2 randomized study evaluating the safety and efficacy of the mutant-selective PI3Kα inhibitor, RLY-2608, in adults and children with PIK3…
This study is a two periods multi-center Phase II trial, with a 6 months double-blind, placebo-controlled period followed by open label period, to assess the ef…